Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/cell.2024.29111.mk | DOI Listing |
Cell Reprogram
January 2025
CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Cell Reprogram
December 2024
CNC - Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Cell Reprogram
December 2024
CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Int J Mol Sci
November 2024
Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland.
Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by disruptions in the dystrophin gene. This study aims to investigate potential a therapeutic approach using genetically modified human iPS-derived mesoangioblast-like cells (HIDEMs) in mouse model. This study utilizes patient-specific myoblasts reprogrammed to human induced pluripotent stem cells (iPSCs) and then differentiated into HIDEMs.
View Article and Find Full Text PDFCell Reprogram
October 2024
CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!